Share
A myriad of AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health, a podcast by a16z Bio + Health and hosted by Kris Tatiossian and Olivia Webb, dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders, operators, and investors Vijay Pande, Julie Yoo, Vineeta Agarwala, and Jorge Conde, along with distinguished guests like Mark Cuban, Greg ...
…
continue reading
Manage episode 512619760 series 2835025
Content provided by Ira Pastor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ira Pastor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dr. Aliza Apple, Ph.D. is a Vice President of Catalyze360 AI ( https://www.lilly.com/science/partners/catalyze-360 ) and Global Head of Lilly TuneLab ( https://tunelab.lilly.com/ ) at Eli Lilly where she leads the strategy, build and launch of Lilly’s external-facing AI/ML efforts for drug discovery.
Lilly Catalyze360 represents a comprehensive approach to enabling the early-stage biotech ecosystem, agnostic of the therapeutic area, designed to accelerate emerging and promising science, strategically removing barriers to support biotech innovation.
In her previous role at Lilly, Dr. Apple served as the COO and head of Lilly Gateway Labs West Coast, where she supported the local biotech ecosystem through early engagement and providing tailored offerings to meet their needs.
Prior to Lilly, Dr. Apple served as a co-founder at Santa Ana Bio, a venture-backed precision biologics company focused on autoimmune disease, and as an advisor to the founders of Firefly Biologics.
Prior to biotech, Dr. Apple was a partner in McKinsey & Co’s life sciences practice. During her nine years at McKinsey in New York and San Francisco, she collaborated with leaders from over 20 biopharma companies to develop their corporate and portfolio strategies, evaluate business development opportunities and improve their organizational effectiveness.
Dr. Apple completed her Ph.D. in bioengineering at UC Berkeley and UCSF, and holds a Bachelor of Science in physics from Georgetown University. She completed a postdoctoral fellowship at Cornell Medical College supported by the NIH Kirschtein National Research Service Award.
#AlizaApple #Catalyze360 #TuneLab #EliLilly #LillyGatewayLabs #DrugDiscoveryModels #SmallMolecules #AntibodyTherapeutics #InSilicoPropertyPredictions #AI #ML #ArtificialIntelligence #MachineLearning #LillyVentures #InnovationHubs #Preclinical #DiscoveryChemistry #StructuralBiology #Toxicology #Immunogenicity #DrugMetabolism #Pharmacokinetics #Pharmacodynamics #ClinicalOperations #SmallMoleculeDrugDevelopment #LargeMoleculeDiscoveryProcess #CorporateVentureCapital #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast
698 episodes
))
